Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 09-2004 | 09-2003 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,788 | N/A | 2,686 | 4,346 | 4,769 |
| Receivables | N/A | N/A | N/A | 27 | 51 |
| TOTAL | $21,958 | $N/A | $2,704 | $4,416 | $4,866 |
| Non-Current Assets | |||||
| PPE Net | 372 | N/A | 1 | 1 | 0 |
| Other Non-Current Assets | 22 | 0 | 2 | 2 | 2 |
| TOTAL | $394 | $N/A | $3 | $3 | $3 |
| Total Assets | $22,352 | $N/A | $2,707 | $4,420 | $4,869 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 163 | 0 | 50 | 53 | 69 |
| Accrued Expenses | 451 | N/A | 10 | 30 | 30 |
| TOTAL | $614 | $N/A | $60 | $83 | $99 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $614 | $N/A | $60 | $83 | $99 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,587 | 102 | N/A | N/A | N/A |
| Common Shares | 3 | N/A | 33 | 33 | 33 |
| Retained earnings | -5,446 | N/A | 2,157 | 2,503 | 2,936 |
| Other shareholders' equity | 0 | 0 | -344 | 0 | 0 |
| TOTAL | $21,738 | $N/A | $2,647 | $4,337 | $4,770 |
| Total Liabilities And Equity | $22,352 | $0 | $2,707 | $4,420 | $4,869 |